Letter to the Editor: Fimasartan-Induced Liver Injury and Update on Hepatotoxicity Risks.
作者信息
Lee Jisoo, Chin Susie, Kim Sang Gyune, Kim Young Seok, Yoo Jeong-Ju
机构信息
Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
Department of Pathology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
出版信息
J Korean Med Sci. 2025 Sep 8;40(35):e271. doi: 10.3346/jkms.2025.40.e271.
Abstract
摘要
相似文献
1
Letter to the Editor: Fimasartan-Induced Liver Injury and Update on Hepatotoxicity Risks.致编辑的信：非马沙坦所致肝损伤及肝毒性风险的最新情况
J Korean Med Sci. 2025 Sep 8;40(35):e271. doi: 10.3346/jkms.2025.40.e271.
2
Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers: A case report.在对其他类型血管紧张素II受体阻滞剂无不良反应的患者中，非马沙坦引起的肝损伤：一例报告。
Medicine (Baltimore). 2017 Nov;96(47):e8905. doi: 10.1097/MD.0000000000008905.
3
The hepatotoxicity assessment of micro/nanoplastics: A preliminary study to apply the adverse outcome pathways.微/纳米塑料的肝毒性评估：应用不良结局路径的初步研究。
Sci Total Environ. 2023 Dec 1;902:165659. doi: 10.1016/j.scitotenv.2023.165659. Epub 2023 Jul 29.
4
Update on the adverse effects of microcystins on the liver.微囊藻毒素对肝脏的不良影响研究进展。
Environ Res. 2021 Apr;195:110890. doi: 10.1016/j.envres.2021.110890. Epub 2021 Feb 19.
5
The protective effect of Schisandra lignans on the hepatotoxicity induced by the metabolic activation of dictamnine.五味子木脂素对由白藓碱代谢活化诱导的肝毒性的保护作用。
J Ethnopharmacol. 2025 Aug 29;352:120170. doi: 10.1016/j.jep.2025.120170. Epub 2025 Jun 18.
6
Risk prediction of hepatotoxicity in paracetamol poisoning.对乙酰氨基酚中毒时肝毒性的风险预测
Clin Toxicol (Phila). 2017 Sep;55(8):879-892. doi: 10.1080/15563650.2017.1317349. Epub 2017 Apr 27.
7
Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers.血管紧张素Ⅱ受体阻滞剂降压治疗期间氨基转移酶升高的发生率和模式。
J Korean Med Sci. 2022 Aug 22;37(33):e255. doi: 10.3346/jkms.2022.37.e255.
8
Hesperidin Reduces Hepatic Injury Induced by Doxorubicin in Rat Model Through Its Antioxidative and Anti-Inflammatory Effects, Focusing on SIRT-1/NRF-2 Pathways.橙皮苷通过其抗氧化和抗炎作用减轻阿霉素诱导的大鼠肝损伤，重点关注SIRT-1/NRF-2信号通路。
J Biochem Mol Toxicol. 2025 Sep;39(9):e70465. doi: 10.1002/jbt.70465.
9
Targeted inhibition of STING-TBK1 axis alleviates the hepatotoxicity of tripterygium glycosides.靶向抑制STING-TBK1轴可减轻雷公藤多苷的肝毒性。
Hum Exp Toxicol. 2025 Jan-Dec;44:9603271251369053. doi: 10.1177/09603271251369053. Epub 2025 Aug 13.
10
Real-world pharmacovigilance assessment of hepatotoxicity risk with HER2-Targeted drugs using FAERS database analysis.使用FAERS数据库分析对HER2靶向药物肝毒性风险进行真实世界药物警戒评估。
Sci Rep. 2025 Aug 6;15(1):28790. doi: 10.1038/s41598-025-14064-2.
本文引用的文献
1
Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea.血管紧张素受体阻滞剂与疑似药物性肝损伤风险：韩国基于电子健康记录通用数据模型的回顾性队列研究。
Drug Saf. 2024 Jul;47(7):673-686. doi: 10.1007/s40264-024-01418-4. Epub 2024 Mar 21.
2
Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers.血管紧张素Ⅱ受体阻滞剂降压治疗期间氨基转移酶升高的发生率和模式。
J Korean Med Sci. 2022 Aug 22;37(33):e255. doi: 10.3346/jkms.2022.37.e255.
3
EASL Clinical Practice Guidelines: Drug-induced liver injury.EASL 临床实践指南：药物性肝损伤。
J Hepatol. 2019 Jun;70(6):1222-1261. doi: 10.1016/j.jhep.2019.02.014. Epub 2019 Mar 27.
4
Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers: A case report.在对其他类型血管紧张素II受体阻滞剂无不良反应的患者中，非马沙坦引起的肝损伤：一例报告。
Medicine (Baltimore). 2017 Nov;96(47):e8905. doi: 10.1097/MD.0000000000008905.
Zotero 插件